Murat Pierre, Guilbaud Guillaume, Sale Julian E
Division of Protein & Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, UK.
Wellcome Sanger Institute, Hinxton, CB10 1RQ, UK.
Nat Commun. 2024 Dec 30;15(1):10850. doi: 10.1038/s41467-024-55148-3.
The rate and pattern of mutagenesis in cancer genomes is significantly influenced by DNA accessibility and active biological processes. Here we show that efficient sites of replication initiation drive and modulate specific mutational processes in cancer. Sites of replication initiation impede nucleotide excision repair in melanoma and are off-targets for activation-induced deaminase (AICDA) activity in lymphomas. Using ductal pancreatic adenocarcinoma as a cancer model, we demonstrate that the initiation of DNA synthesis is error-prone at G-quadruplex-forming sequences in tumours displaying markers of replication stress, resulting in a previously recognised but uncharacterised mutational signature. Finally, we demonstrate that replication origins serve as hotspots for genomic rearrangements, including structural and copy number variations. These findings reveal replication origins as functional determinants of tumour biology and demonstrate that replication initiation both passively and actively drives focal mutagenesis in cancer genomes.
癌症基因组中的诱变速率和模式受到DNA可及性和活跃生物学过程的显著影响。在此我们表明,高效的复制起始位点驱动并调节癌症中的特定诱变过程。复制起始位点在黑色素瘤中阻碍核苷酸切除修复,并且是淋巴瘤中激活诱导脱氨酶(AICDA)活性的脱靶位点。以导管胰腺腺癌作为癌症模型,我们证明在显示复制应激标志物的肿瘤中,DNA合成起始在形成G-四链体的序列处容易出错,从而导致一种先前已被认识但未被表征的突变特征。最后,我们证明复制起点是基因组重排的热点,包括结构变异和拷贝数变异。这些发现揭示了复制起点是肿瘤生物学的功能决定因素,并证明复制起始在癌症基因组中既被动又主动地驱动局部诱变。